Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02232425 · ClinicalTrials.gov registry record · Phase 2
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
A Phase 2 study, sponsored by Ixchelsis Limited.
- Completed
- Registry status
- Phase 2
- Development phase
- 88
- Enrollment target
NCT02232425: Completed Phase 2 study, sponsored by Ixchelsis Limited.
NCT02232425 is a Phase 2 study that has completed, run by Ixchelsis Limited. The registered enrollment target is 88 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02232425, a Phase 2 study, has completed, sponsored by Ixchelsis Limited.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 88 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of IX-01 in men with lifelong premature ejaculation.
Primary Outcome
IX-01 versus placebo. Intravaginal ejaculatory latency time (IELT) was defined as the time from the initiation of sexual intercourse (penetration) until ejaculation occurred
Interventions
- DRUG Placebo
- DRUG IX-01
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-10 |
| Phase | Phase 2 |
What the finished NCT02232425 record still lists
NCT02232425 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02232425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02232425 about?
NCT02232425 is a clinical study titled "IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)". The purpose of this study is to determine the effectiveness of IX-01 in men with lifelong premature ejaculation.
What is the current status of trial NCT02232425?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2014-09. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02232425?
The interventions under investigation include: Placebo (DRUG), IX-01 (DRUG).
Who is sponsoring clinical trial NCT02232425?
This trial is sponsored by Ixchelsis Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02232425's enrollment target sits among peer trials
88 803rd of 2000 higher than 1,191 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia